Study S001382

A Multicenter, Randomized, Open-label, Parallel-controlled Clinical Trial Comparing the Efficacy and Safety of PEG-rhGH Injection Combined with Semaglutide Injection Versus Semaglutide Injection Monotherapy in Body Composition of Non-Diabetic Obese Adults

ClinicalTrials.gov record

Registration

Registration: NCT06863363
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 212
Lead sponsor: Shanghai Zhongshan Hospital
Conditions: Non-diabetic Obesity
Interventions: DRUG:PEG-rhGH Injection + Semaglutide Injection; DRUG:Semaglutide Injection
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

The change in lean body weight (kg) from baseline [Week 40]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.